News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
720,841 Results
Type
Article (46982)
Company Profile (295)
Press Release (673564)
Multimedia
Podcasts (65)
Webinars (12)
Section
Business (209358)
Career Advice (2212)
Deals (36036)
Drug Delivery (114)
Drug Development (82388)
Employer Resources (191)
FDA (16370)
Job Trends (15256)
News (352825)
Policy (33267)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (10)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (10)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (8)
2024 Genetown Digital (5)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (6)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2748)
Academic (2)
Accelerated approval (5)
Adcomms (23)
Allergies (84)
Alliances (51012)
ALS (91)
Alzheimer's disease (1419)
Antibody-drug conjugate (ADC) (129)
Approvals (16366)
Artificial intelligence (268)
Autoimmune disease (22)
Automation (16)
Bankruptcy (367)
Best Places to Work (11834)
BIOSECURE Act (20)
Biosimilars (107)
Biotechnology (201)
Bladder cancer (67)
Brain cancer (26)
Breast cancer (274)
Cancer (2199)
Cardiovascular disease (176)
Career advice (1855)
Career pathing (33)
CAR-T (155)
Cell therapy (427)
Cervical cancer (20)
Clinical research (66676)
Collaboration (842)
Compensation (520)
Complete response letters (21)
COVID-19 (2666)
CRISPR (39)
C-suite (239)
Cystic fibrosis (101)
Data (2110)
Decentralized trials (2)
Denatured (31)
Depression (42)
Diabetes (265)
Diagnostics (6512)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (47)
Drug discovery (123)
Drug pricing (107)
Drug shortages (26)
Duchenne muscular dystrophy (95)
Earnings (87345)
Editorial (38)
Employer branding (25)
Employer resources (161)
Events (115700)
Executive appointments (724)
FDA (17595)
Featured Employer (53)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (771)
Gene editing (105)
Generative AI (22)
Gene therapy (306)
GLP-1 (752)
Government (4566)
Grass and pollen (4)
Guidances (52)
Healthcare (19218)
Huntington's disease (25)
IgA nephropathy (26)
Immunology and inflammation (119)
Indications (28)
Infectious disease (2811)
Inflammatory bowel disease (139)
Inflation Reduction Act (10)
Influenza (51)
Intellectual property (94)
Interviews (352)
IPO (16721)
IRA (42)
Job creations (3842)
Job search strategy (1586)
Kidney cancer (10)
Labor market (41)
Layoffs (484)
Leadership (19)
Legal (8072)
Liver cancer (74)
Lung cancer (319)
Lymphoma (148)
Machine learning (6)
Management (62)
Manufacturing (306)
MASH (67)
Medical device (13519)
Medtech (13524)
Mergers & acquisitions (19843)
Metabolic disorders (693)
Multiple sclerosis (79)
NASH (22)
Neurodegenerative disease (89)
Neuropsychiatric disorders (27)
Neuroscience (1952)
NextGen: Class of 2025 (6726)
Non-profit (4652)
Northern California (2618)
Now hiring (40)
Obesity (377)
Opinion (224)
Ovarian cancer (75)
Pain (84)
Pancreatic cancer (82)
Parkinson's disease (150)
Partnered (21)
Patents (230)
Patient recruitment (107)
Peanut (48)
People (59281)
Pharmaceutical (71)
Pharmacy benefit managers (18)
Phase I (20766)
Phase II (29348)
Phase III (21878)
Pipeline (1146)
Policy (140)
Postmarket research (2643)
Preclinical (9020)
Press Release (72)
Prostate cancer (101)
Psychedelics (32)
Radiopharmaceuticals (252)
Rare diseases (381)
Real estate (6229)
Recruiting (72)
Regulatory (22694)
Reports (55)
Research institute (2477)
Resumes & cover letters (376)
Rett syndrome (4)
RNA editing (4)
RSV (44)
Schizophrenia (70)
Series A (136)
Series B (86)
Service/supplier (14)
Sickle cell disease (55)
Southern California (2250)
Special edition (15)
Spinal muscular atrophy (150)
Sponsored (30)
Startups (3784)
State (2)
Stomach cancer (14)
Supply chain (68)
Tariffs (33)
The Weekly (32)
United States (22850)
Vaccines (705)
Venture capitalists (43)
Weight loss (250)
Women's health (37)
Worklife (18)
Date
Last 7 days (649)
Last 30 days (2286)
Last 365 days (33275)
2025 (10035)
2024 (35961)
2023 (40874)
2022 (51944)
2021 (56525)
2020 (54924)
2019 (47700)
2018 (35970)
2017 (33118)
2016 (32693)
2015 (38795)
2014 (32402)
2013 (27579)
2012 (29834)
2011 (30561)
2010 (29073)
Location
Africa (798)
Alabama (53)
Alaska (7)
Arizona (239)
Arkansas (14)
Asia (39555)
Australia (6518)
California (5994)
Canada (1977)
China (511)
Colorado (268)
Connecticut (266)
Delaware (140)
Europe (85916)
Florida (884)
Georgia (211)
Hawaii (1)
Idaho (58)
Illinois (536)
India (27)
Indiana (314)
Iowa (11)
Japan (158)
Kansas (104)
Kentucky (26)
Louisiana (11)
Maine (62)
Maryland (885)
Massachusetts (4496)
Michigan (234)
Minnesota (401)
Mississippi (2)
Missouri (82)
Montana (27)
Nebraska (25)
Nevada (61)
New Hampshire (64)
New Jersey (1704)
New Mexico (30)
New York (1713)
North Carolina (993)
North Dakota (8)
Northern California (2618)
Ohio (201)
Oklahoma (14)
Oregon (34)
Pennsylvania (1346)
Puerto Rico (11)
Rhode Island (32)
South America (1175)
South Carolina (22)
South Dakota (1)
Southern California (2250)
Tennessee (102)
Texas (893)
Utah (182)
Virginia (142)
Washington D.C. (66)
Washington State (551)
West Virginia (3)
Wisconsin (61)
720,841 Results for "sight sciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sight Sciences Appoints Gary Burbach to its Board of Directors
April 23, 2025
·
7 min read
Press Releases
Sight Sciences to Report First Quarter 2025 Financial Results on May 8, 2025
April 25, 2025
·
2 min read
Press Releases
Sight Sciences to Debut OMNI® Edge Surgical System at the 2025 ASCRS Annual Meeting, Expanding the OMNI Product Portfolio
April 22, 2025
·
8 min read
Press Releases
Sight Sciences to Present at the 24th Annual Needham Healthcare Conference on April 8th
March 25, 2025
·
2 min read
Press Releases
Sight Sciences to Present at Citi’s 2025 Unplugged MedTech and Life Sciences Access Day
February 14, 2025
·
2 min read
Press Releases
Sight Sciences to Report Fourth Quarter and Full Year 2024 Financial Results on March 5, 2025
February 19, 2025
·
2 min read
Biotech Bay
Sight Sciences Announces the Release of its First Sustainability Report
Sight Sciences, Inc., an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, announced that it has published its first Sustainability Report, highlighting the Company’s sustainability activities, performance, and results from the last three years.
June 10, 2024
·
4 min read
Press Releases
Sight Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Initiates Full Year 2025 Financial Guidance
March 5, 2025
·
19 min read
Press Releases
Sight Sciences to Present Comprehensive Clinical Data on the OMNI® Surgical System at the 2025 American Glaucoma Society Annual Meeting
February 24, 2025
·
10 min read
Business
Sight Sciences to Report First Quarter Financial Results on May 2, 2024
Sight Sciences, Inc. announced it will report financial results for the first quarter ended March 31, 2024, after the market close on Thursday, May 2, 2024.
April 18, 2024
·
2 min read
1 of 72,085
Next
